Atlas Trials

Evaluating the Addition of OK-1 Weekly Paclitaxel in Patients With Endometrial Cancer

Clinical trial NCT07737795 · NOT_YET_RECRUITING

Trial details

NCT number
NCT07737795
Sponsor
University of Oklahoma
Status
NOT_YET_RECRUITING
Phase
Phase 2
Study type
INTERVENTIONAL
Endometrial Cancer
Start date
2026-08-01
Primary completion
2028-08-01
Enrollment
66

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.